ACIP Presentation Slides: September 29, 2021 Meeting
On This Page
Note: These files are not yet 508
Slides will be added as they become available.
September 29, 2021
Welcome & Introductions
- Introduction
Dr. G Lee
Dr. M Wharton
Tick-borne Encephalitis (TBE) Vaccine
- Introduction; Immunogenicity and safety of TBE vaccine; Summary and next steps pdf icon[56 pages]
Dr. K Poehling; Dr. S Hills
Zoster Vaccines
- Introduction pdf icon[10 pages]
Dr. C Kotton - Economics of vaccinating immunocompromised 19–49-year-old adults against herpes zoster in the US pdf icon[17 pages]
Dr. I Ortega-Sanchez - Preliminary EtR regarding use of RZV in immunocompromised adults and next steps pdf icon[79 pages]
Dr. T Anderson
Pneumococcal Vaccines
- Introduction pdf icon[17 pages]
Dr. K Poehling
- Summary of economic models assessing pneumococcal vaccines in US adults pdf icon[30 pages]
Dr. A Leidner - EtR on risk-based use of PCV15 and PCV20 in adults; Considerations for use of PCV15 and PCV20 in adults and next steps pdf icon[101 pages]
Dr. M Kobayashi
Hepatitis B Vaccines
- Introduction pdf icon[4 pages]
Dr. K Ault
- HepB-CpG postmarketing surveillance study pdf icon[23 pages]
Dr. K Bruxvoort - Universal adult HepB: EtR pdf icon[81 pages]
Dr. M Doshani
Orthopoxviruses Vaccines
Page last reviewed: September 29, 2021
Content source: National Center for Immunization and Respiratory Diseases